Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Dynamics of B-Cell Populations in CSF and Blood in Patients Treated with a Combination of Rituximab and Mitoxantrone.
Episode 17 with Dr. Hans Lassmann on the usefulness of animal models for studying multiple sclerosis.
Biogen Idec to acquire Fumapharm AG; Consolidates ownership of oral compound BG-12 being studied for multiple sclerosis
Interferon-β therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome.
Comparative efficacy of switching to natalizumab in active multiple sclerosis.
National MS Society: Research Grants
Spotlight on teriflunomide.
Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders.
Firategrast: natalizumab in a pill?
Clinical Characteristics of Pediatric-Onset and Adult-Onset Multiple Sclerosis in Hispanic Americans.
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: too big to fail?
29th European Committee for Treatment and Research in Multiple Sclerosis Congress
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis.
Cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing forms of multiple sclerosis in the United States.
Time-dependent changes in the brain arachidonic acid cascade during cuprizone-induced demyelination and remyelination.
Environmental factors in multiple sclerosis: Epstein-Barr virus, vitamin D, and cigarette smoking.
Cuprizone demyelination of the corpus callosum in mice correlates with altered social interaction and impaired bilateral sensorimotor coordination.
Frequency and magnitude of interferon β neutralizing antibodies in the evaluation of interferon β immunogenicity in patients with multiple sclerosis.
Episode 30 with Dr. Seema Tiwari-Woodruff on estrogenic compounds and MS
Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.
MS Research Roundup: An Introduction
215ON201 BIIB033 In Acute Optic Neuritis (AON) (RENEW)
Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination.
Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: Yes.
Episode 12 with Professor Gavin Giovannoni on the potential for finding a cure for MS.
Pages
« first
‹ previous
…
54
55
56
57
58
59
60
61
62
…
next ›
last »